TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 68 filers reported holding TRINITY BIOTECH PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 815,041 | $15,690,000 | 4.96% |
| Lyon Street Capital, LLC | 570,387 | $10,980,000 | 4.73% |
| Centaur Capital | 135,000 | $2,599,000 | 3.61% |
| GOLDMAN CAPITAL MANAGEMENT INC | 309,690 | $5,962,000 | 3.48% |
| Paradice Investment Management LLC | 584,024 | $11,242,000 | 2.36% |
| RK Capital | 601,672 | $11,582,000 | 2.31% |
| Park West Asset Management LLC | 673,079 | $12,957,000 | 1.89% |
| KEANE CAPITAL MANAGEMENT INC | 95,259 | $1,834,000 | 1.79% |
| Adirondack Research & Management Inc. | 227,052 | $4,371,000 | 1.70% |
| Benchmark Capital Advisors | 92,441 | $1,779,000 | 1.17% |